MIRM - Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver diseases. The company is headquartered in Foster City, California.

52W High

$76.45

52W Low

$36.86

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

0.93

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

39.68

EV/EBITDA (<8 favorable)

-8.85

EV/Revenue (<3 favorable)

8.94

P/S (TTM) (<3 favorable)

8.90

P/B (<3 favorable)

14.98

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

1.86%

Institutions (25–75% balanced)

114.05%

Shares Outstanding

50,238,000

Float

39,985,600

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

429,161,000

Gross Profit (TTM)

339,136,000

EPS (TTM)

-1.21

Profit Margin (>10% good)

-0.14%

Operating Margin (TTM) (higher better)

-0.04%

ROE (TTM) (>15% strong)

-0.24%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.64

Momentum

Bearish momentum

Value

4.6595

5.1059

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025